Exploring how certain natural compounds can help treat substance use disorders
Mass Spectrometry Techniques to Identify and Characterize New Indole/Tryptamine Chemical Probes for Understanding Psychedelics' Therapeutic Mechanism in Substance Use Disorders
This study is exploring how certain psychedelics might help people struggling with substance use disorders by looking at how they interact with brain receptors, which could lead to better treatment options for those in need.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11070559 on NIH RePORTER |
What this research studies
This research investigates the therapeutic mechanisms of psychedelics, particularly those containing tryptamine, in treating substance use disorders (SUDs). By utilizing advanced mass spectrometry techniques, the study aims to identify and characterize new chemical probes that can interact with specific serotonin receptors. This approach seeks to improve the understanding of how these compounds alleviate symptoms associated with SUDs, potentially leading to more effective treatments. Patients may benefit from insights gained about the natural products that could be used in therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with substance use disorders who are seeking alternative therapeutic options.
Not a fit: Patients who do not have substance use disorders or those who are not interested in psychedelic therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, more effective treatments for individuals struggling with substance use disorders.
How similar studies have performed: Previous research has shown promise in using psychedelics for treating substance use disorders, indicating that this approach may yield significant insights.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Christopher, Michael — University of Florida
- Study coordinator: Christopher, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.